Background: Parathyroid cancer (PC) is a rare sporadic or hereditary malignancy whose histologic features were redefined with the 2022 WHO classification. A total of 24 Italian institutions designed this multicenter study to specify PC incidence, describe its clinical, functional, and imaging characteristics and improve its differentiation from the atypical parathyroid tumour (APT).
Methods: All relevant information was collected about PC and APT patients treated between 2009 and 2021.
Purpose: To describe the clinical features of a paediatric cohort affected by differentiated thyroid cancer (DTC) followed in a tertiary Department of Paediatric Endocrinology.
Methods: Clinical data of 41 patients affected by DTC in the 2000-2020 period were reviewed.
Results: The main risk factor was autoimmune thyroiditis (39%).
Background: Aim of the present study was to evaluate the clinical impact of fluorine-F-fluorodeoxyglucose PET/CT (F-FDG-PET/CT) concurrent with post-therapeutic whole-body radioiodine scan (TxWBS) after first radioiodine (RAI) treatment in patients with high-risk differentiated thyroid carcinoma (DTC).
Methods: This was a retrospective, single-center study including 39 patients with DTC (22 females, 17 males, median age 54; IQR: 35-60 years, 87% papillary thyroid cancer, 13% follicular thyroid cancer). All patients underwent F-FDG-PET/CT and RAI treatment, both performed off L-T4 about 3 months after total thyroidectomy.